Tirzepatide and caffeine do not have a listed drug interaction in the current Zepbound prescribing information. Coffee is not automatically off-limits. It may still feel different, though, because tirzepatide can slow stomach emptying, cause nausea, nudge heart rate upward, and leave a person short on fluid after vomiting or diarrhea. Caffeine can overlap with some of those effects.
The honest answer is less dramatic than a ban: there is no direct interaction on the label, and there is also no controlled trial showing how the combination affects an individual person.
Tirzepatide and caffeine: what the label says
As of September 18, 2026, the day this article was written, the FDA's Zepbound label, revised in August 2026, does not mention caffeine. Its drug-interactions section covers two areas: insulin or an insulin secretagogue, a medicine that prompts the pancreas to release insulin, and oral medicines whose absorption may change because tirzepatide delays gastric emptying. Gastric emptying simply means food and liquid moving out of the stomach.
The August revision added a warning about diabetic retinopathy, damage to the light-sensitive tissue at the back of the eye, in people with type 2 diabetes; it did not add a coffee or caffeine interaction. The label also says Zepbound may be used with or without meals. That is a label fact about the medicine, not proof that coffee will feel comfortable on an empty stomach.
This is the same kind of distinction made for tirzepatide and alcohol: the absence of a named interaction does not erase the practical ways two effects can overlap.
Why the same coffee can feel rougher on the stomach
Nausea is common in the branded-product trials behind the label. It was reported by 25% to 29% of people taking Zepbound, depending on dose, compared with 8% on placebo, a look-alike injection without tirzepatide. Vomiting affected 8% to 13% versus 2%. Most nausea, vomiting, and diarrhea appeared while doses were increasing and eased over time.
No trial has tested whether coffee on an empty stomach makes tirzepatide nausea worse. Still, the symptom overlap is easy to understand. Someone who already finds coffee acidic or nauseating may notice that more when food is sitting in the stomach longer or appetite is low. Milk, cream, sweeteners, and a large drink can also change what the stomach is handling, so the reaction may not come from caffeine alone.
That is why a pattern matters more than a universal rule. The tirzepatide meal plan explains how smaller eating occasions fit a reduced appetite; it does not turn coffee into a forbidden food.
Heart rate: two effects, no combined number
The Zepbound label reports an average heart-rate increase of 1 to 3 beats per minute in its two combined weight-reduction trials, compared with no average increase on placebo. That is a group average, not a prediction for one person.
Caffeine can cause a noticeable racing or pounding feeling in some people, particularly at higher amounts or when their usual intake changes. But no published trial has measured the heart-rate effect of caffeine and tirzepatide together. It would be inaccurate to add the label's 1-to-3-beat figure to a caffeine estimate and call that the combined result. Palpitations, dizziness, chest discomfort, or a resting heart rate that feels wrong belong in a conversation with the prescribing clinician.
Coffee is not automatically dehydrating
The fluid question needs a little untangling. In a 2014 controlled study in which 50 habitual male coffee drinkers tried coffee and water on separate days, four 200 mL servings of coffee over a day produced no meaningful difference from water in total body water, 24-hour urine volume, or several blood and urine hydration measures. That small, short study does not cover every person or a very high-caffeine energy drink, but it pushes back on the idea that an ordinary cup always dries the body out.
Tirzepatide's warning is about something more concrete. The label describes kidney injury after volume depletion, meaning the body has lost too much fluid, mostly when nausea, vomiting, or diarrhea continued. Coffee may still count toward fluid intake; it cannot make up for fluid losses that are ongoing or liquids that will not stay down. That is a medical issue, not a coffee-choice problem.
Sleep, tiredness, and energy drinks
Caffeine can hide tiredness for a few hours while making the next night's sleep worse. In a 2025 controlled trial in which 23 men tried caffeine and placebo on separate days, a single 400 mg caffeine dose changed sleep when taken within 12 hours of bedtime, while 100 mg did not produce a significant difference in the tested windows. The study was small and enrolled men only, so its numbers are context, not a personal cutoff.
That matters because fatigue is already reported with tirzepatide. Adding more caffeine can turn a low-energy day into a poor-sleep cycle without explaining why the tiredness started. What tirzepatide tiredness can mean covers the other possibilities, including low food intake, fluid loss, and low blood sugar when certain diabetes medicines are involved.
Energy drinks are a bigger unknown, not a cleaner answer. No controlled study has tested tirzepatide with an energy drink, including sugar-free products. A can may combine a large caffeine amount with other stimulants, acidity, carbonation, or sweeteners, so a reaction cannot be pinned on one ingredient. The same evidence gap applies to semaglutide.
What belongs in the prescriber conversation
The useful details are the actual drink and serving size, total caffeine from coffee, tea, energy drinks, pre-workout products or tablets, when symptoms appear, and whether insulin or a sulfonylurea is also being used. A prescriber can then separate a stomach issue from a heart-rate concern, poor sleep, dehydration, or low blood sugar.
Through Promise, tirzepatide is dispensed as a compounded medication, which is different from an FDA-approved product: the formulation offered here is not FDA-approved. A licensed provider may still prescribe a compounded formulation; that decision is between the patient and the doctor. At Promise, a licensed U.S. provider reviews every request, and not everyone qualifies.